TGM2 and neoplasm: Both selected compounds, [11C]1 and [18F]2, were able to discriminate between active and inactive tissue transglutaminase in vitro and demonstrated specific and selective binding to MDA-MB-231 tumour sections, as assessed by in vitro autoradiography experiments.